[Feature] "Dermare (DERMARE)" Succeeds in Developing Seaweed PDRN

Published Dec 31, 2025

Tridge summary

Found in seaweed... PDRN as a 'vegan regenerative material' replaces the reliance on salmon roe with seaweed Seaweed raw materials and by-products as bio materials Raw material suppliers such as Dongkuk Pharmaceutical and Kolmar Korea have their final goal of entering the medical field market In the regenerative medicine and beauty markets, PDRN (polydeoxyribonucleotide) is a widely known material. Extracted from salmon sperm, this substance has been expanding the market due to its wound healing and skin regeneration effects. However, behind this growth, there were also structural limitations. These include a raw material structure dependent on specific fish species, high prices, and supply instability due to climate change. Amid these limitations, the marine bio startup Dermare (DERMARE

Original content

PDRN found in seaweed… attracting attention as a ‘vegan regenerative material’ Replacing the salmon-dependent structure with seaweed Using raw seaweed and by-products as bio materials Raw material supply from Dongkuk Pharmaceutical, Kolmar Korea, etc. Final goal is to enter the medical field market Dermare was established based on the research achievements of All-in-One Jintech, which developed a diagnostic kit for aquatic diseases. In the early days of the startup, All-in-One Jintech developed a kit to diagnose diseases in aquaculture farms early, but the response from the field was different from expectations. There was a strong perception that diagnosing diseases was burdensome, and there was also considerable concern that the disclosure of diseases could lead to disadvantages. This experience became the catalyst for resetting the business direction. Han Ji-sung, CEO of Dermare, said, “We still produce and sell the kit, but we realized that there are market limitations just by ...

Source: Fisheco